| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | 0.043 | 0.8 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.0072 | 0.8 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.8 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | -0.026 | 0.8 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.007 | 0.8 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.9 |